Everolimus (RAD001) has since been utilized as a single chemotherapeutic drug as well as in combination for different malignancies, including HER2-positive breast cancer and neuroendocrine tumors [54]. The gene discussed is ERBB2; the disease is neuroendocrine neoplasm.